March 12, 2012

UBS YIELD OPTIMIZATION NOTES INVESTMENT LOSSES

The Soreide Law Group is investigating claims on behalf of investors purchasing UBS Yield Optimization Notes. UBS’ Yield Optimization Notes are also known as reverse convertibles. Reverse convertibles are esoteric structured products based upon the performance of a short put option, or derivative. Reverse convertibles are attractive to investors seeking income because of the above average income the product provides. However, this income product has substantial risk of loss of principal. The income comes from the premium received from the sale of a put on the underlying stock. Surprisingly, UBS does not mandate its registered representatives to perform option suitability analysis or have investors fill out options account forms. As a result, investors, including retirees, without options investing experience can been sold complicated option laden reverse convertibles.
 
UBS is one of several firms that are under investigation by the State of Georgia for improper reverse convertible sales. Georgia securities regulators are not alone, the State of Massachusetts is also investigating how firms are selling reverse convertibles to investors. The SEC is also investigating whether the risks and fees of reverse convertibles were properly disclosed to investors. In addition, the SEC is investigating whether investors overpaid for reverse convertibles. Recognizing potential sales abuses associated with reverse convertibles, FINRA issued Notice to Members 10-09, which was a reminder to firms of their disclosure obligations under NTM 05-59. Members are required to provide balanced risk disclosures to investors purchasing reverse convertibles. In 2011, FINRA began conducting regulatory sweeps to monitor how members were selling reverse convertibles to investors. FINRA has subsequently issued NTM 12-03 which seeks heightened supervision for complex products such as reverse convertibles.
 
If you or a loved on has purchased UBS Yield Optimization Notes or a reverse convertible product call Lars K. Soreide of the Soreide Law Group at 888-760-6552 for a free consultation or visit https://www.securitieslawyer.com.
 
 
S H A R E   T H I S   P O S T

Recent Posts

July 6, 2026
Gary Frisch Connected To Avantax Investor Arbitration Claim About Unauthorized Trading

Investors potentially experienced sales practice violations by securities broker Gary Bryan Frisch [CRD: 5037164, Surprise, Arizona], according to public information found on Financial Industry Regulatory Authority (FINRA) BrokerCheck. Frisch worked for Avantax Investment Services Inc. and Avantax Advisory Services from October 25, 2019, through September 5, 2025, and has been registered with Cetera Wealth Services […]

July 6, 2026
Christopher Chlupp Faced Robert W. Baird Investor Arbitration Claim About Mismanagement

Investors potentially incurred losses because of securities broker Christopher Frederick Chlupp [CRD: 2950578, Wisconsin Dells, Wisconsin], given the disclosures on Financial Industry Regulatory Authority (FINRA) BrokerCheck. Chlupp has worked for Robert W. Baird Co. Incorporated as a securities broker since June 25, 1998, and as a financial advisor since September 24, 1998. Keep reading to […]

July 6, 2026
Robert Jones Linked To Great Point Capital Client Arbitration Claim About Breach Of Fiduciary Duty

Investors might have sustained losses due to securities broker Robert Hunter Jones [CRD: 5169688, Lakewood, Colorado], based on publicly available information on Financial Industry Regulatory Authority (FINRA) BrokerCheck. Jones worked for Great Point Capital LLC from December 13, 2019, to May 1, 2026, and has been registered with Quincy Wells Capital LLC since May 1, […]

Contact us Nationwide USA
2401 E. Atlantic Blvd., Suite 305, Pompano Beach, FL 33062
Helping clients recover money across the USA
search
Copyright © 2025 Soreide Law Group, PLLC  |  All Rights Reserved